Biosergen AB (8N10) Stock Price & News

All values in SEK	Sep. 2025	Des. 2025	Mrt. 2026	Jun. 2026
Revenue	131,00 k	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	12,73 m	5,88 m	5,33 m	5,33 m
Operating expense	12,19 m	9,67 m	5,24 m	5,24 m
Total operating expenses	12,19 m	9,67 m	5,24 m	5,24 m
Operating income	-12,19 m	-9,67 m	-5,24 m	-5,24 m
Other non operating income	-	-	-	-
EBT including unusual items	-12,17 m	-9,66 m	-5,24 m	-5,24 m
EBT excluding unusual items	-12,17 m	-9,66 m	-5,24 m	-5,24 m
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-537,00 k	3,79 m	-95,50 k	-95,50 k
Net income	-12,17 m	-9,66 m	-5,24 m	-5,24 m
Net profit margin	-	-	-	-
Earnings per share	-5,00	-	-	-
Interest and investment income	22,00 k	18,00 k	-	-
Interest expense	-	-4,00 k	-7,50 k	-7,50 k
Net interest expenses	22,00 k	14,00 k	-7,50 k	-7,50 k
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-	-	-	-

Ask anything